- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03370978
Text Messaging Follow-up From ED
The Role of Text Messaging in Follow-up Appointments for Patients Discharged From the Emergency Department
Study Overview
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 18 years old
- Able to read, write and communicate in English - English as the primary language
- Has a phone with capabilities for text messaging
- Identifies oneself as someone who is comfortable with text messaging.
- To follow-up with Family Medicine as outpatient (Scheduled through Emergency Department Nurse Navigators).
- Evaluated in the University of Iowa Hospitals and Clinics Emergency Department
Exclusion Criteria:
- Absence of one or more inclusion criteria
- Not able to provide informed consent or participate due to limited decision-making ability.
- Prisoner
- Previously has followed with the University of Iowa Hospitals and Clinics Family Medicine (i.e., would not be a "new" patient establishing care).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Text Messaging
Receives text messages to remind of upcoming follow-up appointment with primary care doctor.
Also provides opportunity for subjects to text ED staff for follow-up care concerns or to reschedule primary care appointment.
|
To communicate with intervention patients after discharge from the ED, we will use a bidirectional text messaging service provided by another physician's research group within the University of Iowa. The nurse navigator will enter the patient's study identification number, first and last name and cell phone onto a secure study website established by this research group. Patients will, as previously mentioned, have had their cell phone number tested in the text messaging system prior to leaving the Emergency Department (this includes the control group). Patient's will receive a text message 3 days, and 1 day, prior to their scheduled follow-up appointment with Family Medicine (this appointment having been scheduled through the Emergency Department Nurse Navigators). Each text message will remind the patient of the date/time of their appointment, and provide them a link containing a map with the location of their appointment. |
|
No Intervention: Usual Care
Received usual care including follow-up phone calls if clinically indicated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attending Primary Care Appointment
Time Frame: Less than 6 months
|
Attending appointment versus rescheduling versus not showing
|
Less than 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 201607734
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.